| Category: | Medical & Pharma, Pharmaceuticals |
|---|---|
| Organizer: | Orbit Exhibitions Pvt. Ltd. |
| Exhibition center: | Chennai Trade Center (CTC) |
Hotels search near to Chennai Trade Center (CTC)
Overview interest facts - Pharmac South 2024
PHARMAC SOUTH 2024 - 9th Edition stands out as a leading Pharmaceutical, Nutraceutical & Contract Manufacturing, Exhibition & Conference, attracting participants ranging from manufacturers to trade professionals across various sectors including Pharma Machinery, Analytical Instruments, Lab Equipment, Herbal, and Cosmetics. Regarded as a cornerstone event for the pharmaceutical and allied industries, it offers a valuable platform for gaining insights into industry trends, engaging with key technical and regulatory figures, and fostering dialogue with associated stakeholders.
Attendees benefit from the opportunity to network and exchange perspectives with prominent suppliers of pharmaceutical products and services, making PHARMAC SOUTH an essential event for industry professionals.
Overview of exhibitors / visitors - Pharmac South 2024
Contract Manufacturers, Contract Research Organizations (CROS), Nutraceutical Product/ Dietary Supplements, Ayurvedic / Herbal Products, Pharmaceutical Machinery, Pharmaceutical Formulation & Apl's, Pharmaceutical Bulk Drugs, Veterinary Drugs, Additives, Intermediates, Pharmaceutical Printing & Packaging, Pharma Ancillary & Utility Services & Maintenance, Software For Pharmaceutical Industry & Management, Bio-pharmaceuticals/ Bio Lab Instruments & Equipment, Pharmaceutical Engineering/Refrigeration, Clean Room Technology, Analytical Laboratory Supplies (instruments, Glassware, Lab Reagents -chemicals), Banks/ Financial Sectors Focusing On Pharma Industry, Trade Promotion Bodies -technical Publications/ Trade Associations/ Media/ Publications, Patent/ Trade Mark Lawyers.
Recommended events
Recommended events
News
AstraZeneca adds to rare blood disease portfolio with world-first Voydeya approval in Japan
A month after Novartis made its entry into the paroxysmal nocturnal haemoglobinuria (PNH) field, AstraZeneca’s newest contender Voydeya bolsters the company’s presence...
22 January 2024New material improves treatment of complex bone infections
Researchers in Ireland have combined antimicrobial implants and gene therapies to develop a new surgical solution with the potential to improve the treatment of comple...
29 November 2023Sepsis - as common as cancer, as deadly as a heart attack
In 2016, the research team conducted an initial study in southern Sweden (Skåne) where they revealed that sepsis is much more common than previously believed.
04 September 2023FDA approves first oral treatment for postpartum depression
Following the approval, Biogen plans for the commercial launch Zurzuvae (zuranolone) in Q4 2023.
10 August 2023New blood test finds two thirds of cancers
A new multi-cancer early detection blood test could speed up diagnosis.
16 June 2023EU Proposes Drug Manufacturing Overhaul, Faces Pushback
The European Union on April 26 has released a draft of the probable and proposed revamp of its drug manufacturing laws
04 May 2023